The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial
dc.contributor.author | Spostol, Richard | en_US |
dc.contributor.author | Ertel, Inta J. | en_US |
dc.contributor.author | Jenkin, R. D. T. | en_US |
dc.contributor.author | Boesel, Carl P. | en_US |
dc.contributor.author | Venes, Joan L. | en_US |
dc.contributor.author | Ortega, Jorge A. | en_US |
dc.contributor.author | Evans, Audrey E. | en_US |
dc.contributor.author | Waral, William | en_US |
dc.contributor.author | Hammond, Denman | en_US |
dc.date.accessioned | 2006-09-11T16:00:34Z | |
dc.date.available | 2006-09-11T16:00:34Z | |
dc.date.issued | 1989-07 | en_US |
dc.identifier.citation | Spostol, Richard; Ertel, Inta J.; Jenkin, R. D. T.; Boesel, Carl P.; Venes, Joan L.; Ortega, Jorge A.; Evans, Audrey E.; Waral, William; Hammond, Denman; (1989). "The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial." Journal of Neuro-Oncology 7(2): 165-177. <http://hdl.handle.net/2027.42/45395> | en_US |
dc.identifier.issn | 0167-594X | en_US |
dc.identifier.issn | 1573-7373 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/45395 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2550594&dopt=citation | en_US |
dc.description.abstract | Fifty-eight patients with high-grade astrocytoma were treated by members of the Childrens Cancer Study Group in a prospective randomized trial designed to study the effectiveness of chemotherapy as an adjuvant to standard surgical treatment and radiotherapy. Following surgical therapy, patients were assigned randomly to radiotherapy with or without chemotherapy consisting of chloroethyl-cyclohexyl nitrosourea, vincristine, and prednisone. Treatment with chemotherapy prolonged survival and event-free survival. Five-year event-free survival was 46% for patients in the radiotherapy and chemotherapy group, and 18% for patients in the radiotherapy-alone group. Five-year survival was similarly improved. The differences in outcome due to treatment were statistically significant after correcting for imbalances in important prognostic factors (event-free survival, p = 0.026; survival, p = 0.067). The presence of mitoses or necrosis in the tumor specimen was associated with poorer outcome. Patients whose initial surgery was limited to biopsy, and patients with basal ganglia lesions, also had significantly worse outcome. Chemotherapy administered at the time of recurrence in a small number of patients did not produce any long-term survivors. This study is to our knowledge the only randomized trial to investigate effectiveness of chemotherapy in the treatment of high-grade astrocytoma in children. | en_US |
dc.format.extent | 875683 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; Springer Science+Business Media | en_US |
dc.subject.other | Astrocytoma | en_US |
dc.subject.other | Children | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Oncology | en_US |
dc.subject.other | Glioblastoma Multiforme | en_US |
dc.subject.other | Chemotherapy | en_US |
dc.subject.other | Randomized Trial | en_US |
dc.title | The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor | en_US |
dc.contributor.affiliationother | Ohio State University, Columbus | en_US |
dc.contributor.affiliationother | Mott Childrens Hospital, Ann Arbor | en_US |
dc.contributor.affiliationother | School of Medicine, University of California, San Francisco | en_US |
dc.contributor.affiliationother | University of Southern California School of Medicine, Los Angeles | en_US |
dc.contributor.affiliationother | Childrens Hospital of Los Angeles, USA | en_US |
dc.contributor.affiliationother | Toronto-Bayview Cancer Center, USA | en_US |
dc.contributor.affiliationother | University of Southern California School of Medicine, Los Angeles | en_US |
dc.contributor.affiliationother | Children's Hospital of Philadelphia, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 2550594 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/45395/1/11060_2004_Article_BF00165101.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00165101 | en_US |
dc.identifier.source | Journal of Neuro-Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.